Using ultrasonography to determine thyroid size and prevalence of goiter in lithium-treated patients with affective disorders

Journal of Affective Disorders

Volumn 104, Issue 1-3, 2007, Pages 45-51

  Bauer, Michael ^a,b   Blumentritt, Holger ^c   Finke, Reinhard ^d   Schlattmann, Peter ^e   Adli, Mazda ^b,f   Baethge, Christopher ^b,g   Bschor, Tom ^b,h   Müller Oerlinghausen, Bruno ^b,f   Berghöfer, Anne ^b,f  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b International Group for the Study of Lithium Treated Patients (IGSLI)   (Germany)

^c PAUL EHRLICH INSTITUT   (Germany)

^d Praxisgemeinschaft an der Kaisereiche   (Germany)

^e Institute for Medical Informatics   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g UNIVERSITY OF COLOGNE   (Germany)

^h Jewish Hospital Berlin   (Germany)

Author keywords

Affective disorders; Goiter; Lithium; Thyroid gland; Ultrasonography

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; LEVOTHYROXINE; LITHIUM; NEUROLEPTIC AGENT; THYROTROPIN;

ADULT; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GERMANY; GOITER; HUMAN; LITHIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD DISORDER; PALPATION; PREVALENCE; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; THYROID WEIGHT; THYROTROPIN BLOOD LEVEL;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GOITER; HUMANS; LITHIUM CARBONATE; MALE; MIDDLE AGED; PREVALENCE; PSYCHOTIC DISORDERS; THYROID GLAND;

EID: 35748980256     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.01.033     Document Type: Article

References (36)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (3rd Edition-Revised) DSM-III-R (1987), American Psychiatric Association, Washington, DC
2. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am. J. Psychiatry 159 (2002) 1-50 (suppl.)
3. Baethge C., Smolka M.N., Gruschka P., Berghöfer A., Schlattmann P., Bauer M., Altshuler L., Grof P., and Müller-Oerlinghausen B. Does prophylaxis delay in bipolar disorders influence outcome? Results from a long-term study of 147 patients. Acta Psychiatr. Scand. 107 (2003) 260-267
4. Baethge C., Baldessarini R.J., Mathiske-Schmidt K., Hennen J., Berghöfer A., Müller-Oerlinghausen B., Bschor T., Adli M., and Bauer M. Long-term combination versus monotherapy with lithium and carbamazepine in 46 bipolar I patients. J. Clin. Psychiatry 66 (2005) 174-182
5. Baethge C., Blumentritt H., Berghöfer A., Bschor T., Glenn T., Adli M., Schlattmann P., Bauer M., and Finke R. Long-term lithium treatment and thyroid antibodies - a controlled study. J. Psychiatry Neurocsi. 30 (2005) 423-427
6. Bauer M., and Döpfmer S. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. J. Clin. Psychopharmacol. 19 (1999) 427-434
7. Bauer M., Bschor T., Kunz D., Berghöfer A., Ströhle A., and Müller-Oerlinghausen B. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. Am. J. Psychiatry 157 (2000) 1429-1435
8. Bauer M., Whybrow P.C., Angst J., Versiani M., and Möller H.J. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 2: maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J. Biol. Psychiatry 3 (2002) 69-86
9. Brunn J., Block U., Ruf G., Bos I., Kunze W.P., and Scriba P.C. Volumetrie des Schilddrüsenlappens mittels Realtime-Sonographie. [Volumetric analysis of thyroid lobes by real-time ultrasound]. Dtsch. Med. Wochenschr. 106 (1981) 1338-1340
10. Crossley, N.A., Bauer, M., in press. Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomised placebo-controlled trials. J Clin Psychiatry.
11. Crossley N.A., Müller-Oerlinghausen B., Glenn T., and Bauer M. The position of lithium in international and national guidelines for the treatment of mood disorders. In: Bauer M., Grof P., and Müller-Oerlinghausen B. (Eds). Lithium in Neuropsychiatry - The Comprehensive Guide (2006), Informa Healthcare, Oxfordshire 33-42
12. Davis J.M. Lithium maintenance of unipolar depression. In: Bauer M., Grof P., and Müller-Oerlinghausen B. (Eds). Lithium in Neuropsychiatry - The Comprehensive Guide (2006), Informa Healthcare, Oxfordshire 99-108
13. Grunze H., Kasper S., Goodwin G., Bowden C., Baldwin D., Licht R.W., Vieta E., and Möller H.J. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part II: treatment of mania. World J. Biol. Psychiatry 4 (2003) 5-13
14. Grunze H., Kasper S., Goodwin G., Bowden C., and Möller H.J. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J. Biol. Psychiatry 5 (2004) 120-135
15. Gutekunst R., Becker W., Hehrmann R., Olbricht T., and Pfannenstiel P. Ultraschalldiagnostik der Schilddrüse. Dtsch. Med. Wochenschr. 113 (1988) 1009-1112
16. Hampel R., Kühlberg T., Klein K., Jerichow J.U., Pichmann E.G., Clausen V., and Schmidt I. Strumaprävalenz in Deutschland gröβer als bisher angenommen. Med. Klin. 90 (1995) 324-329
17. Head L., and Dening T. Lithium in the over-65s: who is taking it and who is monitoring it? A survey of older adults on lithium in the Cambridge Mental Health Services catchment area. Int. J. Geriatr. Psychiatry 3 (1998) 164-171
18. Hegedüs L., and Bennedbaek F.N. Nonisotopic techniques of thyroid imaging. In: Braverman L.E., and Utiger R.D. (Eds). Werner and Ingbar's The Thyroid. A Fundamental and Clinical Text. 9th edition (2005), Lippincott Williams & Wilkins, Philadelphia 373-383
19. Hegedüs L., Bonnema S.J., and Bennedbaek F.N. Management of simple nodular goiter: current status and future perspectives. Endocr. Rev. 24 (2003) 102-132
20. Jarlov A.E., Nygaard B., Hegedus L., Hartling S.G., and Hansen J.M. Observer variation in the clinical and laboratory evaluation of patients with thyroid dysfunction and goiter. Thyroid 8 (1998) 393-398
21. Kleiner J., Altshuler L., Hendrick V., and Hershman J.M. Lithium-induced subclinical hypothyroidism: review of the literature and guidelines for treatment. J. Clin. Psychiatry 60 (1999) 249-255
22. Knudsen N., Bols B., Bulow I., Jorgensen T., Perrild H., Ovesen L., and Laurberg P. Validation of ultrasonography of the thyroid gland for epidemiological purposes. Thyroid 9 (1999) 1069-1074
23. Kushner J.P., and Wartofsky L. Lithium-thyroid interactions. In: Johnson F.N. (Ed). Lithium and the Endocrine System (1988), Karger, Basel 74-98
24. Lazarus J.H. The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid 8 (1998) 909-913
25. Lazarus J.H., Kirov G., and Harris B.B. Effect of lithium on the thyroid and endocrine glands. In: Bauer M., Grof P., and Müller-Oerlinghausen B. (Eds). Lithium in Neuropsychiatry - The Comprehensive Guide (2006), Informa Healthcare, Oxfordshire 259-270
26. Liang K.Y., and Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 73 (1986) 13-22
27. Lombardi G., Panza N., Biondi B., Di Lorenzo L., Lupoli G., Muscettola G., Carella C., and Bellastella A. Effects of lithium treatment on hypothalamic-pituitary-thyroid axis: a longitudinal study. J. Endocrinol. Investig. 16 (1993) 259-263
28. Loviselli A., Bocchetta A., Mossa P., Velluzzi F., Bernardi F., del Zompo M., and Mariotti S. Value of thyroid echography in the long-term follow-up of lithium-treated patients. Neuropsychobiology 36 (1997) 37-41
29. Müller-Oerlinghausen B., Berghöfer A., and Bauer M. Manic-depressive disorder. Lancet 359 (2002) 241-247
30. Ozpoyraz N., Tamam L., and Kulan E. Thyroid abnormalities in lithium-treated patients. Adv. Ther. 19 (2002) 176-184
31. Perrild H., Hegedüs L., Baastrup P.C., Kayser L., and Kastberg S. Thyroid function and ultrasonically determined thyroid size in patients receiving long-term lithium treatment. Am. J. Psychiatr. 147 (1990) 1518-1521
32. Schiemann U., and Hengst K. Thyroid echogenicity in manic-depressive patients receiving lithium therapy. J. Affect. Disord. 70 (2002) 85-90
33. Shulman K.I., Sykora K., Gill S.S., Mamdani M., Anderson G., Marras C., Wodchis W.P., Lee P.E., and Rochon P. New thyroxine treatment in older adults beginning lithium therapy. Am. J. Geriatr. Psychiatry 13 (2005) 299-304
34. Tunbridge W.M.G., Evered D.C., Hall R., Appleton D., Brewis M., Clark F., Grimley E.J., Young E., Bird T., and Smith P.A. The spectrum of thyroid disease in a community: the Whickham survey. Clin. Endocrinol. (Oxf.) 7 (1977) 481-493
35. Voelzke H., Luedemann J., Robinson D.M., Spieker K.W., Schwahn C., Kramer A., John U., and Meng W. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 13 (2003) 803-810
36. Yatham L.N., Kennedy S.H., O'Donovan C., Parikh S., MacQueen G., McIntyre R., Sharma V., Silverstone P., Alda M., Baruch P., Beaulieu S., Daigneault A., Milev R., Young L.T., Ravindran A., Schaffer A., Connolly M., Gorman C.P., and Canadian Network for Mood and Anxiety Treatments. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord. 7 Suppl 3 (2005) 5-69